Private company values — are they really dropping?
The median valuation of U.S. private companies dropped from the six-year high reached late last year, but remains higher than a year ago, according to the latest quarterly valuation report from Dow Jones VentureOne.
Valuations on venture-backed companies are negotiated by venture capitalists and entrepreneurs. If valuations head lower, that is not great for companies because it means they give away a larger stake of their company for the dollars they get from venture capitalists.
At $18.5 million for the first quarter of 2007, the median pre-investment valuation is modestly above the $16.4 million median recorded in the first quarter of 2006, but slightly below the $20 million median it topped out at in the fourth quarter of last year. See the full data here (downloads excel file).
This comes after a report last week by law firm Fenwick & West showing that a greater percentage of companies negotiated higher valuations in follow-on rounds than in any other quarter on record (79 percent of SF Bay Area companies negotiated up rounds vs. 9 percent down). This suggests the investment climate is still hot.
The two reports are compatible. Overall valuations can decline slightly, even as a greater percentage of companies negotiate higher valuations than their previous rounds (its just that the overall levels of those valuations are not as high as the quarter before). Confused? Well, put simply, we’ll have to wait another quarter or two to see if things are really cooling down.
Biopharmaceutical companies posted the most significant increase in values, according to the Dow Jones report, with the median valuation rising to $28 million from $15 million in the first quarter of 2006. The healthcare industry overall, however, was down with the median valuation dropping to $22.1 million in the current quarter from $27 million a year ago.
Information technology company valuations held steady from a year ago, at a median $15.4 million, although each segment within the IT category posted some declines during the most recent quarter, according to the data.
Finally, it’s worth noting that later-round valuations, which fell in the fourth quarter, rose in the most recent quarter — reflecting the heavy action right now in the M&A and IPO markets, where more mature companies are getting snapped up by other companies or going public. The $41 million median price set in all companies raising a third or later round was the highest since the second quarter of 2001, when it was $42.9 million.
[Disclosure: Fenwick & West is a sponsor of VentureBeat]
Next Story: GooTube strikes deal with EMI, after label shuns DRM with Apple
Previous Story: Mahalo.com emerges as yet another search engine
About the Author, Matt Marshall
Matt launched VentureBeat in September of 2006, with the realization that no one else was covering the entrepreneurial and tech innovation scene with the velocity or depth that he was. Prior to founding VentureBeat, he covered venture capital for the San Jose Mercury News from 2001 to 2006. In 2002, Matt was awarded "Journalist of the Year" by the Northern California Society of Professional Journalists. Prior to working at the Merc, he was a correspondent for the Wall Street Journal in Bonn, Germany from 1995 to 1998, and a writer for the Washington Post in 1994. Matt holds a PhD in Government and an MA in German and European Studies from Georgetown University. In addition to VentureBeat, Matt is also the Executive Producer of DEMO, the leading launchpad event for emerging technologies.
